Circulating Reticulocalbin 1 and Reticulocalbin 3 in Systemic Sclerosis Patients: Results of a Case Control Study.

@article{Blnescu2016CirculatingR1,
  title={Circulating Reticulocalbin 1 and Reticulocalbin 3 in Systemic Sclerosis Patients: Results of a Case Control Study.},
  author={P. Bălănescu and Anca Lădaru and E. Bălănescu and V. Pompilian and D. Gologanu and S. Caraiola and C. Băicuș and G. Dan},
  journal={Clinical laboratory},
  year={2016},
  volume={62 6},
  pages={
          1109-16
        }
}
BACKGROUND Proteomic candidate biomarkers for systemic sclerosis (Ssc) useful for appropriate patient evaluation and follow-up were identified in mass-spectrometry studies; however, most of these biomarkers were not evaluated and confirmed on independent patient samples. Up-regulation of reticulocalbin 1 (RCN1) and reticulocalbin 3 (RCN3) in the dermal fibroblast secretome originating from Ssc patients was previously described. The aim of the study was to evaluate circulating RCN1 and RCN3 as… Expand